10.59USD+4.59%Mkt Cap: 95.44M USDP/E: —Last update: 2026-05-26
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap95.44M USD
Enterprise Value96.52M USD
Revenue (TTM)29.93M USD
Gross Profit11.45M USD
Net Income (TTM)-1.04M USD
Revenue/Share3.310 USD
Last Price10.59 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees73
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-91.00
PEG—
EV/EBITDA16.41
EV/Revenue3.22
P/S3.03
P/B3.35
EPS (TTM)-0.07
EPS (Forward)-0.11
52W Range
4.52098% of range10.74
52W High10.74 USD
52W Low4.520 USD
Profitability
Gross Margin41.40%
Oper. Margin19.01%
EBITDA Margin19.65%
Profit Margin-3.76%
ROE-3.84%
ROA-2.45%
Growth
Revenue Growth28.40%
Earnings Growth31.30%
Cash Flow & Leverage
Operating CF2.48M USD
CapEx (TTM)1.25M USD
FCF Margin10.29%
FCF Yield3.23%
Net Debt5.96M USD
Net Debt/EBITDA1.01
Balance Sheet
Debt/Equity0.49
Current Ratio4.82
Quick Ratio2.43
Book Value/Sh2.991 USD
Cash/Share0.7530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJul 25, 1990
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.05M
Float6.00M
Insiders32.10%
Institutions21.70%
Short Interest
Short Ratio0.7d
Short % Float0.24%
Short % Out.0.20%
Shares Short18.19K
Short (prev mo.)34.25K
Technical
SMA 507.613 (+39.0%)
SMA 2006.503 (+62.8%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)31.43K
Avg Vol (10d)36.38K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—